MXPA03003425A - Moleculas de agrecanasa novedosas. - Google Patents

Moleculas de agrecanasa novedosas.

Info

Publication number
MXPA03003425A
MXPA03003425A MXPA03003425A MXPA03003425A MXPA03003425A MX PA03003425 A MXPA03003425 A MX PA03003425A MX PA03003425 A MXPA03003425 A MX PA03003425A MX PA03003425 A MXPA03003425 A MX PA03003425A MX PA03003425 A MXPA03003425 A MX PA03003425A
Authority
MX
Mexico
Prior art keywords
novel aggrecanase
aggrecanase molecules
disclosed
enzymes
aggrecanase
Prior art date
Application number
MXPA03003425A
Other languages
English (en)
Inventor
Lisa Anne Racie
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Publication of MXPA03003425A publication Critical patent/MXPA03003425A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describen proteinas de agrecanasa y las secuencias nucleotidicas que las codifican, asi como los procesos para producirlas. Tambien se describen metodos para desarrollar inhibidores de las enzimas de agrecanasa y anticuerpos para las enzimas para el tratamiento de condiciones caracterizadas por la degradacion del agrecano.
MXPA03003425A 2000-10-20 2001-10-17 Moleculas de agrecanasa novedosas. MXPA03003425A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24231700P 2000-10-20 2000-10-20
PCT/US2001/032596 WO2002034895A2 (en) 2000-10-20 2001-10-17 Novel aggrecanase molecules

Publications (1)

Publication Number Publication Date
MXPA03003425A true MXPA03003425A (es) 2004-05-04

Family

ID=22914296

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003425A MXPA03003425A (es) 2000-10-20 2001-10-17 Moleculas de agrecanasa novedosas.

Country Status (13)

Country Link
EP (1) EP1326967A2 (es)
JP (2) JP2004512043A (es)
AU (1) AU2002245758A1 (es)
BR (1) BR0114719A (es)
CA (1) CA2426463A1 (es)
CZ (1) CZ2003996A3 (es)
MX (1) MXPA03003425A (es)
NO (1) NO20031649L (es)
NZ (1) NZ525368A (es)
PL (1) PL362008A1 (es)
SK (1) SK4632003A3 (es)
WO (1) WO2002034895A2 (es)
ZA (1) ZA200303865B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI802576B (zh) 2017-06-02 2023-05-21 德商馬克專利公司 與ａｄａｍｔｓ結合之免疫球蛋白

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391610B1 (en) * 1999-08-06 2002-05-21 The Cleveland Clinic Foundation Nucleic acids encoding zinc metalloproteases
WO2001023561A2 (en) * 1999-09-27 2001-04-05 Curagen Corporation Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats

Also Published As

Publication number Publication date
JP2004512043A (ja) 2004-04-22
EP1326967A2 (en) 2003-07-16
SK4632003A3 (en) 2004-05-04
PL362008A1 (en) 2004-10-18
CZ2003996A3 (cs) 2004-04-14
NZ525368A (en) 2006-03-31
BR0114719A (pt) 2004-01-27
NO20031649L (no) 2003-06-11
JP2008301813A (ja) 2008-12-18
ZA200303865B (en) 2004-08-19
WO2002034895A3 (en) 2002-10-10
CA2426463A1 (en) 2002-05-02
WO2002034895A2 (en) 2002-05-02
AU2002245758A1 (en) 2002-05-06
NO20031649D0 (no) 2003-04-10

Similar Documents

Publication Publication Date Title
MX2010001481A (es) Proteasas fungales acidas.
SG158739A1 (en) Aggrecanase molecules
DE60030988D1 (de) Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH
ATE346938T1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
DK1337629T3 (da) Dipeptidylpeptidaser
WO2002031134A3 (en) Novel serine protease genes related to dppiv
DE60331321D1 (de) Verfahren zur wirksamen rna-interferenz in säugerzellen
DE10345772A1 (de) Verfahren zur Herstellung von 3-Methylamino-1-(thien-2-yl)-propan-1-ol
DE602004024686D1 (de) Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit
ATE324386T1 (de) Verfahren zum quellen
WO2002033093A3 (en) Aggrecanase molecules
MXPA03011715A (es) Moleculas de agrecanasa.
WO2003064597A3 (en) Aggrecanase molecules
MXPA03003425A (es) Moleculas de agrecanasa novedosas.
WO2002042439A3 (en) Aggrecanase adamts9
SG160194A1 (en) Truncated aggrecanase molecules
WO2003012038A3 (en) Aggrecanase molecules
WO2003057842A3 (en) Aggrecanase molecules
EA200700287A1 (ru) Улучшенные ферменты
DK1639119T3 (da) Fremgangsmåde til mikrobiologisk isomerisering af alpha-hydroxycarboxylsyrer
ATE420950T1 (de) Verfahren zur herstellung von lipasen
NO20053829D0 (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
UA49751A (uk) Спосіб визначення концентрації тетрапептидного с-кінцевого фрагмента вазопресину у водному розчині

Legal Events

Date Code Title Description
FG Grant or registration